Impact of Renal Dysfunction on Cardiac Outcomes and ESRD in HF Patients With Mitral Regurgitation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial
Eur Heart J 2022 Feb 03;[EPub Ahead of Print], N Beohar, G Ailawadi, LN Kotinkaduwa, B Redfors, M Simonato, Z Zhang, LG Morgan, E Escolar, S Kar, DS Lim, JM Mishell, BK Whisenant, WT Abraham, J Lindenfeld, MJ Mack, GW StoneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.